How many insider trades does FilingIQ track for YDES?

FilingIQ tracks 6 Form 4 insider transactions for YDES (YD Bio Ltd), covering filings from Mar 31, 2026 onwards. 6 of those were filed in the last 90 days.

Are YDES insiders net buyers or net sellers?

Across the full Form 4 history for YDES, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does YDES insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is YDES in?

YD Bio Ltd (YDES) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $523.97M.

YDES insider trading

NasdaqGM Healthcare

YD Bio Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$523.97M

About YD Bio Ltd

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Company website: www.ydesgroup.com

YDES insider activity at a glance

FilingIQ has scored 6 insider transactions for YDES since Mar 31, 2026. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live YDES trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for YDES?: FilingIQ tracks 6 Form 4 insider transactions for YDES (YD Bio Ltd), covering filings from Mar 31, 2026 onwards. 6 of those were filed in the last 90 days.
Are YDES insiders net buyers or net sellers?: Across the full Form 4 history for YDES, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does YDES insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is YDES in?: YD Bio Ltd (YDES) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $523.97M.

Methodology & sources

Every YDES insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.